NCT06805448View on ClinicalTrials.gov

Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 21, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Sjorgren's Syndrome
Interventions
DRUG

MSC

Allogeneic adipose-derived mesenchymal stromal / stem cells in 10% DMSO

DRUG

Saline Water (Control)

Isotonic sterile saline water

Trial Locations (1)

2100

RECRUITING

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER